Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation in Schizophrenia
NCT00000371Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 1996
- Primary completion
- Apr 2002
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of d-cycloserine in schizophrenia, sponsored by Massachusetts General Hospital. Started Aug 1996; status: completed.
02
Drugs
d-cycloserine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00000371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000371.